top of page

News & Press

Hot News

[Seminar] Molecular characterization of breast tumors and tumor microenvironment among Chinese breast cancer patients in Hong Kong

Updated: Mar 25



The JC School of Public Health and Primary Care of The Chinese University of Hong Kong (CUHK) is pleased to host a seminar on the topic, “Molecular characterization of breast tumors and tumor microenvironment among Chinese breast cancer patients in Hong Kong” by Dr. Rose Yang, Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, on 28 March 2024. Please refer to details below:

  Molecular characterization of breast tumors and tumor microenvironment among Chinese breast cancer patients in Hong Kong

Date:

28 March 2024 (Thursday)

Time:

12:30 pm – 2:00 pm (HKT)

Venue:

KCTCRC, 1/F, School of Public Health Building, Prince of Wales Hospital

Speaker:

Dr. Rose Yang

Integrative Tumor Epidemiology Branch,

Division of Cancer Epidemiology & Genetics,

National Cancer Institute




About the Speaker


Dr. Rose Yang is a Senior Investigator at the Division of Cancer Epidemiology & Genetics, National Cancer Institute in the United States. She received a Ph.D. in Physiology from the Lombardi Cancer Center at Georgetown University in 1999, followed by an M.P.H. in Epidemiology from the Johns Hopkins Bloomberg School of Public Health in 2003. Dr. Yang's research focuses primarily on examining the etiologic and molecular heterogeneity of breast cancer, as well as exploring the genetics of chordoma and familial cutaneous malignant melanoma/dysplastic nevi syndrome. In her current work on breast cancer, Dr. Yang characterizes the molecular profiles of tumors and tumor microenvironment (TME) using integrated tumor profiling analysis to identify distinct genomic features and their associations with risk factors in diverse populations. Her presentation will describe her work on Asian breast cancer, with a special emphasis on the molecular characterization of breast tumors derived from the Hong Kong breast cancer study.

75 views
bottom of page